Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication

INTRODUCTION: A Direct Healthcare Professional Communication (DHPC) sent in Denmark on 11 August 2011 provided information on new pioglitazone labelling and guidance on monitoring treatment effectiveness. We describe pioglitazone use in Denmark after the DHPC, estimate the incidence of heart failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Cid Ruzafa, Javier, Ulrichsen, Sinna Pilgaard, Bennett, Dimitri, Ehrenstein, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702533/
https://www.ncbi.nlm.nih.gov/pubmed/31376066
http://dx.doi.org/10.1007/s40801-019-0160-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702533/
https://www.ncbi.nlm.nih.gov/pubmed/31376066
http://dx.doi.org/10.1007/s40801-019-0160-6

Ejemplares similares